Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Laryngoscope. 2012 Dec;122(Suppl 5):S107–S125. doi: 10.1002/lary.23735

Table 2.

Glycosaminoglycans

Years After Treatment 1&2 1&2 10 10
Gene ID Gene Symbol up down up down
ILMN_1668760 HAS3 9.4 hyaluronan synthase 3 (HAS3), transcript variant 1,
ILMN_1794501 HAS3 4.2 2.8 hyaluronan synthase 3 (HAS3), transcript variant 1,
ILMN_1792978 HAS2 2.4 2.4 hyaluronan synthase 2 (HAS2),
ILMN_2243036 HAS2 −2.5 hyaluronan synthase 2 (HAS2),
ILMN_1754716 HAS1 −3.2 −47.3 hyaluronan synthase 1 (HAS1),
ILMN_1787548 HSPG2 −2.7 heparan sulfate proteoglycan 2 (HSPG2),
ILMN_1787548 HSPG2 −2.7 heparan sulfate proteoglycan 2 (HSPG2),
ILMN_2228035 HS3ST1 2.5 heparan sulfate (glucosamine) 3-O-sulfotransferase 1 (HS3ST1),
ILMN_1710416 HS3ST6 5.4 heparan sulfate (glucosamine) 3-O-sulfotransferase 6 (HS3ST6),
ILMN_1667432 HYAL3 −2.5 hyaluronoglucosaminidase 3 (HYAL3),
ILMN_2165463 HAPLN4 −2.7 hyaluronan and proteoglycan link protein 4 (HAPLN4),
ILMN_1712620 HYAL1 −4.2 hyaluronoglucosaminidase 1 (HYAL1), transcript variant 1,
ILMN_1740407 CHSY3 4.6 chondroitin sulfate synthase 3 (CHSY3),
ILMN_2165463 HAPLN4 −2.7 hyaluronan and proteoglycan link protein 4 (HAPLN4),
ILMN_2117845 CSPG4LYP2 −13.3 chondroitin sulfate proteoglycan 4-like, Y-linked pseudogene 2 (CSPG4LYP2), non-coding RNA.